ICD code definitions

CPT® Code 82626: Dehydroepiandrosterone (DHEA)

May 29, 2026
3 min read
CPT® Code 82626: Dehydroepiandrosterone (DHEA)

CPT® Code 82626 is used to report quantitative measurement of dehydroepiandrosterone (DHEA), an adrenal hormone that serves as a precursor to androgens and estrogens. DHEA testing is commonly used to evaluate adrenal function, hormonal balance, and endocrine disorders.

This code represents the laboratory assay only, not specimen collection or interpretation services, which may be reported separately when appropriate.

Key Facts About CPT® 82626

  • Service type: Laboratory test
  • Test: DHEA (quantitative)
  • Specimen type: Typically serum or plasma
  • Test purpose: Evaluate adrenal and hormonal function
  • Provider type: Laboratories, physicians, and qualified healthcare professionals

Common clinical indications:

  • Evaluation of adrenal function
  • Assessment of androgen excess or deficiency
  • Investigation of hormonal imbalances
  • Workup of conditions such as adrenal disorders or PCOS
  • Functional and integrative hormone panels

When to Use CPT® 82626

CPT 82626 is appropriate when:

  • Measuring DHEA levels to assess adrenal hormone production
  • Evaluating endocrine or hormonal disorders
  • Investigating symptoms such as fatigue, hormonal imbalance, or androgen excess
  • Monitoring hormone-related treatment plans

Examples:

  • Assessing adrenal function in a patient with chronic fatigue
  • Evaluating androgen levels in a patient with suspected hormonal imbalance
  • Including DHEA in a comprehensive hormone panel
  • Monitoring endocrine treatment or hormone therapy

Documentation Requirements

To support CPT 82626 billing, documentation should include:

  • Patient identifiers and date of service
  • Clinical indication for testing
  • Specimen type (e.g., serum, plasma)
  • Test performed (DHEA measurement)
  • Test result and date reported
  • Ordering provider information

Clear documentation supports medical necessity, accurate billing, and continuity of care.

Reimbursement and Coding Considerations

  • CPT 82626 is generally covered when medically necessary, though coverage may vary
  • Diagnosis coding should support endocrine or hormonal indications
  • Specimen collection may be billed separately if allowed
  • Often performed alongside related tests (e.g., DHEA-S, cortisol, testosterone)
  • Some payers may consider this test specialized and apply additional review

Always verify payer-specific laboratory billing requirements.

How OptiMantra Supports Hormone Testing

OptiMantra’s integrated EMR and practice management platform streamlines documentation and billing for CPT 82626:

With OptiMantra, providers can:

  • Order DHEA and related hormone tests within the patient chart
  • Track hormone levels longitudinally for ongoing care
  • Link lab results to symptoms, diagnoses, and treatment plans
  • Maintain organized laboratory documentation that supports billing compliance and audit preparedness
  • Integrate functional and conventional hormone workflows

By centralizing hormone testing workflows, OptiMantra helps practices improve efficiency, ensure compliance, and optimize reimbursement.

Try OptiMantra for free here!

Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.

Jessica Castro
Jessica Castro

Jessica is a Massachusetts-based LPN with 13+ years of experience in patient care, healthcare technology, and education. As the Implementation and Customer Success Manager at OptiMantra, she helps providers optimize EMR solutions for better workflows and patient outcomes. With a Bachelor's in Community Health and a Master's in Healthcare Innovation in progress, she is passionate about leveraging technology to improve care delivery. Through her writing, she shares insights on healthcare best practices, EHR optimization, and patient advocacy to support providers in delivering exceptional care.